Literature DB >> 8249918

Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method.

S Y Lin1, P H Chen, C K Wang, J D Liu, C P Siauw, Y J Chen, M J Yang, M H Liu, T C Chen, J G Chang.   

Abstract

A rapid, simple, and nonradioactive method for diagnosing point mutations of c-K-ras oncogenes in gastroenterologic cancers is described. This method involved the selective amplification of DNA fragments from cancer tissues of surgical specimens with specific oligonucleotide primers, followed by digestion with restriction enzymes that recognized artificially created or naturally occurring restriction sites. To detect codon 12 mutations, an artificial Msp I site was created by introducing a single nucleotide mismatch into the 5' mutagenesis primer. Using a similar approach, an Hae III site was created to detect codon 13 mutations. Bal I and MBo II sites were used to detect codon 61 mutations. A total of 61 gastroenterologic cancer cases were studied. Of 35 cases of colorectal cancer, 7 showed mutations: 6 at codon 12 and 1 at codon 13. In 1 of 2 cases of cholangiocellular carcinoma, point mutation at codon 12 was found. One case of duodenal cancer showed point mutation at codon 12. No mutations were found in the cases of hepatocellular carcinoma (4), gastric cancer (12), esophageal cancer (3), or pancreatic cancer (2).

Entities:  

Mesh:

Year:  1993        PMID: 8249918     DOI: 10.1093/ajcp/100.6.686

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Epigenetics modulates the effect of chemotherapy on gastric cancer.

Authors:  Yoshiyuki Watanabe; Fumio Itoh
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

2.  Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

Authors:  R F Caduff; C M Johnston; T S Frank
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

3.  Absence of ras gene mutations in early gastric carcinomas.

Authors:  M E Craanen; P Blok; B Top; L Boerrigter; W Dekker; G J Offerhaus; G N Tytgat; S Rodenhuis
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

4.  K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas.

Authors:  D Bartsch; D Bastian; P Barth; A Schudy; C Nies; O Kisker; H J Wagner; M Rothmund
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

5.  Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers.

Authors:  J G Chang; T H Su; H J Wei; J C Wang; Y J Chen; C P Chang; C J Jeng
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

6.  Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Authors:  Ya-Sian Chang; Kun-Tu Yeh; Tien-Jye Chang; Connie Chai; Hsiu-Chin Lu; Nicholas C Hsu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2009-06-11       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.